PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsAlarm over proposal to overturn US ban on patenting human genes

BioNews

Alarm over proposal to overturn US ban on patenting human genes

Published 7 June 2019 posted in News and appears in BioNews 1001

Author

Kulraj Singh Bhangra

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

A bill that would nullify the US Supreme Court decision that banned the patenting of human genes is being debated by the US Congress...

A bill that would nullify the US Supreme Court decision that banned the patenting of human genes is being debated by the US Congress. 

Scientists and patient advocacy groups have expressed concern that proposed changes to Section 101 of the Patent Act would restrict the public exchange of information and latest research findings. This could impede the development of novel tests, treatments, and targeted therapies, leading to increased costs for patients, researchers and healthcare systems.

The draft bill would result in a 'quagmire of patent claims and legal impediments to the normal scientific exchange', according to Professor Harold Varmus a cancer biologist at Weill Cornell Medicine, New York. 'It's in the interest of virtually everyone to keep ideas and basic discoveries about the laws and products of nature in the public domain.'

The contentious issue of patenting human genes was often in the news (see BioNews 543) until 2013, when Myriad Genetics' patents on BRCA1 and BRCA2 were revoked by the US Supreme Court (see BioNews 709), ending their monopoly and allowing other laboratories to enter the testing marketplace. Myriad had been sued by the American Civil Liberties Union (ACLU) who argued that genes should not be patentable because they are 'products of nature'. The Supreme Court agreed, holding that 'laws of nature', 'natural phenomena' and 'abstract ideas' cannot be patented. 

The proposed bill would amend Section 101 of the Patent Act, removing these and any other 'judicially created exceptions to subject matter availability' and abrogating 'all cases establishing or interpreting those exceptions'. The bill aims to improve innovation within the pharmaceutical sector and see new therapies developed. However, because these would have monopolies, they could be more expensive to patients. 

The ACLU released a letter appealing to lawmakers, supported by 169 signatories representing organisations including scientific societies, research institutions and patient advocacy groups. 

Senator Christopher Coon, who proposed the bill said: 'I want to be clear on one thing…Our proposal would not change the law to allow a company to patent a gene as it exists in the human body.' 

Professor Arti K Rai, a patent law expert at Duke University in Durham, North Carolina, agrees that the novelty requirement for a patent rules out patenting most genes since the human genome is already in the public domain. However, she told Wired that the proposed law could affect applications to patent methods to estimate a person's disease risk across multiple genes, such as polygenic risk scores, where patents are already being sought. 

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
12 October 2015 • 2 minutes read

BRCA gene cannot be patented, says Australia's High Court

by Cait McDonagh

An isolated gene sequence cannot be patented, Australia's highest court has unanimously ruled. It is the latest and final decision in litigation that has lasted over five years...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
19 June 2015 • 3 minutes read

Cancer patient appeals gene patenting decision

by Paul Waldron

Australia's highest court will decide whether isolated molecules of DNA linked to a gene mutation associated with an increased risk of hereditary breast and ovarian cancers are patentable under Australian law....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
5 September 2014 • 3 minutes read

Australian federal court throws out appeal on gene patenting

by Matthew Thomas

Gene sequences isolated from the human body are patentable, according to a ruling by the Australian federal court...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
14 June 2013 • 4 minutes read

US Supreme Court: Human DNA is a 'product of nature' and cannot be patented

by Dr Sarah West

The US Supreme Court has unanimously rejected a number of patent claims made by Myriad Genetics on isolated forms of two genes, BRCA1 and BRCA2, associated with an increased risk of breast and ovarian cancer....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
21 March 2013 • 3 minutes read

Myriad Genetics: landmark ruling for gene patenting

by Dr Sarah West

In the latest instalment of a highly contested case, the US Federal Circuit Court of Appeals in Washington DC upheld Myriad Genetics' right to patent two genes, BRCA1 and BRCA2,which are associated with the risk of breast and ovarian cancer....

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Gene mutation in genome-edited babies linked to shorter life

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

6 July 2022 • 1 minute read

Frozen embryo transfers linked to high blood pressure in pregnancy

5 July 2022 • 1 minute read

Anorexia in pregnancy linked to increased risk of complications

5 July 2022 • 2 minutes read

Pregnancy after breast cancer treatment does not increase risk of recurrence

5 July 2022 • 1 minute read

No difference between fresh and frozen sperm for IUI

4 July 2022 • 2 minutes read

Shorter IVF protocol reduces risk of OHSS

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856